Andere Sprachen Orchid Pharma Limited Bombay S.E.

Aktien

A404BH

INE191A01027

ORCHPHARMA

Markt geschlossen - Bombay S.E. Andere Börsenplätze 12:00:48 17.05.2024			% 5 Tage	% 1. Jan.
1.091 ^INR	+1,05 %		+5,31 %	+52,80 %

12.04.	Orchid Pharma Limited kündigt Rücktritt von Mudit Tandon als unabhängiges Mitglied des Verwaltungsrats an	CI
23.02.	Orchid Pharma erhält die Zulassung der US Food and Drug Administration für seine neuartige Erfindung	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

PUFE Transactions Under IBC	14.05.
Orchid Pharma Limited Announces Resignation of Mudit Tandon as Independent Director	12.04.
Orchid Pharma : Iii. Un-audited Financial Results for the quarter ended December 31, 2023 - Dec 31,2023	12.04.
Orchid Pharma : Un-audited Financial Results for the quarter ended June 30, 2023 - June 30,2023	12.04.
Orchid Pharma : Un-audited Financial Results for the quarter and half year ended September 30, 2023 - Sep 30,2023	12.04.
Orchid Pharma Receives United States Food and Drug Administration Approval for Its Novel Invention	23.02.
Orchid Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08.02.
European Medicines Agency Grants Approval for Orchid Pharma's 'Exblifep'	30.01.
Orchid Pharma Limited Appoints Kapil Dayya as Company Secretary & Compliance Officer	16.12.
Orchid Pharma Limited Announces Resignation of Marina Peter as Company Secretary and Compliance Officer	14.12.
Orchid Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	04.11.
Orchid Pharma Limited Approves the Appointment of Mr. Arjun Dhanuka as Additional Director (In Capacity of Non-Executive & Non-Independent)	20.10.23
Orchid Pharma Ties Up with GARDP to Manufacture Antibiotic for Certain Gram-Negative Infections	12.09.23
Orchid Pharma Limited Enters into Manufacturing Sub License Agreement with Global Antibiotic Research & Development Partnership	12.09.23
Orchid Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10.08.23
Orchid Pharma : Notice of 30th AGM.	18.07.23
Orchid Pharma : Annual Report 2022-2023	18.07.23
Orchid Pharma Raises INR4 Billion Via Qualifed Institutional Placement	28.06.23
Orchid Pharma : NOMINATION AND REMUNERATION POLICY	13.06.23
Orchid Pharma : Audited Financial Result for the quarter and Financial year ended March 31, 2023 - May 10,2023	11.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Orchid Pharma Limited Bombay S.E.

Aktien

A404BH

INE191A01027

ORCHPHARMA

Andere Sprachen

Filter